Public and Private Investments and Federal Grants Contribute to Total

Colorado’s life sciences community raised $1.2 billion in the first two quarters of 2024. Public and private capital, as well as federal and state grants contributed to the fundraising totals January 1, 2024-June 30, 2024.  

The continued strong fundraising comes after CNBC highlighted the fundraising momentum of Colorado’s life sciences community during its “Cities of Success” special report. The ecosystem’s fundraising now stands at $11 billion raised in the last seven years and six months.  

“Colorado is the Hub for Health Impact, with life sciences financings surging past the billion-dollar mark in the first two quarters of 2024,” said Elyse Blazevich, President & CEO of Colorado BioScience Association. “Health innovations from Colorado save and change lives around the world and investors want to seize opportunities here.”

Fundraising Totals

In the first two quarters of 2024, Colorado companies raised $794.6 million in public capital through M&A, post-IPO debt, and post-IPO equity. Companies and the state’s academic and research institutions also received $257.9 million in state, federal and foundation grants. Colorado life sciences companies also raised $155.3 million in private capital.

Venture Capital Totals  

Pre-Seed and Seed: $8.9M

Series A and B: $111.4M

Series C, D, and Later: $35M

Colorado Life Sciences Financing History

2024 Q1 and Q2: $1.2 billion

2023: $1.47 billion

2022: $1.6 billion

2021: $2.4 billion

2020: $1.2 billion, $2.6 billion including Invitae acquisition of ArcherDX

2019: $850 million, $12.1 billion including Pfizer acquisition of Array Biopharma

2018: $1 billion

2017: $1.2 billion

Colorado BioScience Association compiles and analyzes annual life sciences financings using publicly available sources, including company news releases, media reports, SEC filings, federal and state databases, and Crunchbase.